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Abstract
Background
Visceral leishmaniasis (VL) is a multifactorial disease, where the host genetics play a signifi-
cant role in determining the disease outcome. The immunological role of anti-inflammatory cy-
tokine, Interleukin 10 (IL10), has been well-documented in parasite infections and considered
as a key regulatory cytokine for VL. Although VL patients in India display high level of IL10 in
blood serum, no genetic study has been conducted to assess the VL susceptibility / resis-
tance. Therefore, the aim of this study is to investigate the role of IL10 variations in Indian VL;
and to estimate the distribution of disease associated allele in diverse Indian populations.
Methodology
All the exons and exon-intron boundaries of IL10 were sequenced in 184 VL patients along
with 172 ethnically matched controls from VL endemic region of India.
Result and Discussion
Our analysis revealed four variations; rs1518111 (2195 A>G, intron), rs1554286 (2607 C>T,
intron), rs3024496 (4976 T>C, 3’ UTR) and rs3024498 (5311 A>G, 3’UTR). Of these, a vari-
ant g.5311A is significantly associated with VL (χ2=18.87; p =0.00001). In silico approaches
have shown that a putative micro RNA binding site (miR-4321) is lost in rs3024498 mRNA.
Further, analysis of the above four variations in 1138 individuals from 34 ethnic populations,
representing different social and linguistic groups who are inhabited in different geographical
regions of India, showed variable frequency. Interestingly, we have found, majority of the trib-
al populations have low frequency of VL (‘A’ of rs3024498); and high frequency of leprosy
(‘T’ of rs1554286), and Behcet’s (‘A’ of rs1518111) associated alleles, whereas these were
vice versa in castes. Our findings suggest that majority of tribal populations of India carry the
protected / less severe allele against VL, while risk / more severe allele for leprosy and Beh-
cet’s disease. This study has potential implications in counseling and management of VL
and other infectious diseases.
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Introduction
Visceral leishmaniasis (VL), caused by protozoan parasite Leishmania donovani, is the most
severe form of leishmaniasis. After infection, the parasite migrates to internal organs such as
liver, spleen and bone marrow, followed by appearance of complex clinical symptoms, which
can be lethal, if left untreated [1, 2]. In Indian subcontinent, (India, Nepal and Bangladesh)
approximately 150 million people are at risk of developing VL (67% of the world VL disease)
[3–5]. It is considered to be a rural disease and is a big burden for the people, who are in the
villages of Bihar state in India [3, 6, 7]. Genetic, immunological and socio-economical factors
play a role in the disease outcome [6–9].
Human Interleukin-10 (IL10) gene, located on chromosomal region 1q32.1, codes for anti-
inflammatory cytokine. IL10 comprises of 5 exons, covering approximately 4.8 kb (Fig 1). IL10
cytokine is primarily produced by monocytes and to a lesser extent by lymphocytes; namely
type 2 T helper cells (Th2), mastocytes, CD4+CD25+Foxp3+ regulatory T cells, and a certain
subset of activated T cells and B cells [10]. It is also expressed by different cells of the innate im-
mune system, including dendritic cells (DCs), mast cells, natural killer (NK) cells, eosinophils
and neutrophils [11]. IL10 down regulates the expression of Th1 cytokines, major histocom-
patibility complex II (MHC II), co-stimulatory molecules on macrophages and IL-12 [12,13].
IL10 has a stimulatory effect on certain T cells (Th2), mast cells and it stimulates the B cell sur-
vival, proliferation and antibody production [12, 14, 15]. It is also involved in the regulation of
the STAT (Signal transducer and activator of transcription) signalling pathway and inhibit in-
tracellular killing of amastigotes by macrophages [16, 17].
IL10 plays key role in different diseases, such as; hepatitis B, pulmonary tuberculosis, herpes
zoster, cutaneous malignant melanoma, skin squamous cell carcinoma, inflammatory bowel
diseases, human immuno deficiency viruses (HIV), leprosy, schistosomiasis, malaria, filaria
and rheumatoid arthritis [18–29]. IL10 is also widely studied in organ transplantation [22, 30].
VL patients display over expression of IL10 mRNA and high level of IL10 in blood serum [10,
31] (reviewed in [12]). Recent studies on Indian VL demonstrated that disease outcome de-
pends possibly on the balance between pro-inflammatory cytokines (IFN-γ and TNF-α) and
anti-inflammatory (IL-10) responses [32, 33]. Subsequent studies have shown that the func-
tional IL10 polymorphisms are also associated with pulmonary tuberculosis and leprosy in
Indian population [19, 25]. Earlier genetic studies in Sudan, Brazil and Iran have shown the
role of IL10 polymorphisms in visceral leishmaniasis (VL), cutaneous leishmaniasis (CL) and
post kala-azar dermal leishmaniasis (PKDL) respectively [34–36]. However, to the best of our
knowledge no attempt has been made to investigate the role of IL10 in Indian VL. Therefore,
Fig 1. The structure of the human IL10 (chr1, 206945839–206940947; ENST00000423557). Exons of the gene are shown in pink, introns in brown.
rs1518111 (2195 A>G) and rs1554286 (2607 C>T) were the intronic variant of second and third exons while rs3024496 (4976 T>C) and rs3024498 (5311
A>G) were the 3’ UTR variant of fifth exons.
doi:10.1371/journal.pone.0124559.g001
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we have investigated the complete IL10 in ethnically matched VL case-controls. Considering
the fact that, VL is endemic in Bihar state of India and every Indian population is genetically
unique [37], we have also aimed to investigate the distribution of risk / protective / severe al-
leles, observed by the case-control study, among the 34 diverse population of India.
Materials and Methods
Sample collection
A total of 356 subjects, including 184 VL patients and 172 ethnically matched controls in the
Middle Eastern part of India (Bihar state) were included in this study (Table 1). The sampling
area were located within a radius of ~80 kilometer from the city of Muzaffarpur covering the
districts of Muzaffarpur, Patna, Vaisali and Sitamadhi VL endemic regions. The demographic
details of the study region and an annual incidence rate of 2.49 clinical VL cases/1,000 persons
have been described elsewhere [38, 39].
Patients were recruited upon visiting their residence and screening their medical records,
issued by the local government hospitals. Diagnosis of VL was performed at the hospitals by
serological (rK39 strip test) and parasitological methods (light microscopy) using splenic aspi-
rates accompanied by typical clinical features such as; fever, weight loss, fatigue, anaemia, hepa-
tomegaly, splenomegaly and presence of clinical response to anti-leishmanial treatment [1].
Control subjects were recruited from the same geographical region and matched for age, sex
and ethnicity. Both, case and controls are Indo-European speakers and are socially classified as
caste populations. The controls were healthy subjects, who have never been diagnosed with VL
and did not show any family history of VL from the last three generations. The health status of
the control subjects were examines with the help of local health authority and confirmed that
they are healthy. Further, they also confirmed that the healthy subjects were also free from
other infectious diseases (TB, filaria, malaria, etc.) of same geographical region. The mean age
of all cases was 29.38 +/- 17.11, while controls ranged from 38.79 +/- 16.57 (Table 1). The male
to female ratio in cases was 102:82 and in controls was 97:75 (Table 1). From each subject, we
have collected 3–5.0 mL of peripheral blood samples in EDTA vacutainer, with informed writ-
ten consent. Prior permission was also obtained from the district government authority. This
study was approved by the Institutional Ethical Committee (IEC) of CSIR-Centre for Cellular
and Molecular Biology, Hyderabad, India. In addition to case controls, a total of 1138 indi-
viduals from 34 ethnic populations belonging to different social (16 tribal population and 18
caste populations) and linguistic groups (Indo-European, Dravidian, and Austro-Asiatic);
and inhabited in different geographical regions, were also included in this study). These sam-
ples were utilized from the DNA bank of CCMB (Centre for Cellular and Molecular Biology,
Hyderabad).
DNA isolation and IL10 genotyping
Genomic DNA was extracted from whole blood, using the protocol described previously [40].
Reference genomic sequence was retrieved from the Ensembl database [www.ensembl.org].
Primers for PCR and sequencing of five exons and exon-intron boundary were designed using
Table 1. Sample size, mean age and sex ratio of case and control samples.
Case (184) Control (172) P-value
Mean Age (year)+/-SD 29.38 +/- 17.11 38.79 +/- 16.57 0.33581
Male: Female 102:82 97:75 0.9397
doi:10.1371/journal.pone.0124559.t001
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Primer-BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast) and synthesized commer-
cially (Eurofins, India) (Table 2).
We have amplified the target regions using primer pairs (Table 2) and an Emerald PCR
master mix (TaKaRa). The reactions were carried out in an ABI GeneAmp PCR system 9700.
The thermal cycling parameters used were as follows: initial denaturation at 95°C for 5 min-
utes, followed by 35 cycles of denaturation at 94°C for 1 minute, annealing for 30 seconds and
elongation at 72°C for 1 minute (Table 2). PCR amplification was followed by Exo-SAP treat-
ment (USB Corporation, USA), following manufacturer’s protocol. Exo-SAP treated amplicons
were sequenced directly using BigDye terminator (v.3.1) cycle sequencing kit (Applied Biosys-
tems, USA) on an ABI 3730XL DNA analyser. Sequence variations were identified by assem-
bling DNA sequences with the reference sequence using AutoAssembler software (Applied
Biosystems, USA). Variations obtained were validated and reconfirmed in a subset of samples
by re-sequencing and visual confirmation of electropherograms.
Statistical analysis
The target sample size was determined using PS software (Power and Sample Size Calculation
Software Package, Vanderbilt University, Nashville, TN). The allele and genotype frequencies
were calculated by simple gene counting method and Expectation Maximum (EM) algorithm.
Hardy-Weinberg equilibrium and Chi-square tests were computed using PLINK software
(Purcell et. al, 2007, options used:—assoc,—hwe 0.01). p value of< 0.05 was considered signifi-
cant. Further, p value was corrected for multiple testing and adjusted as function of R base
package [41]. Linkage disequilibrium (LD) analysis was performed using Haploview (v4.2). In
addition, genetic models such as allelic, dominant and recessive were examined to evaluate the
distribution of the genotype and allelic frequencies. In-silicomethods were used to predict
miRNA binding sites for wild and mutant (rs3024498) mRNA, using RegRNA online tool.
Results
We estimated that 184 cases and 172 controls were required for each study to achieve 88%
power, with 95% confidence, and 5% precision to detect a variable with an odds ratio of 2.0
(based on the assumption of 30% exposure among controls). Further, we have investigated the
entire coding region of IL10 in study subjects, with non-significant difference in age and gender
distribution (Table 1), and found four variations (SNPs): rs1518111 (2195 A>G, intron 2;
Table 2. Primer sequence, GC% and annealing temperature of IL10 exons.
Primer Sequence GC% Tm Annealing temperature
IL10_1F GGTTAGAGAAGGAGGAGCTCTAAGCA 50 60
IL10_1R GGCGCAGGAGGAGGGTTCTT 65 58 60
IL10_2F GGGCATCAAAAAGACCGCATTTCAGT 46 58
IL10_2R TGTCCCTGCTGGTCTGTAGGA 57 56 58
IL10_3 & 4F TCCCAGGGCCATGGAAGCAG 65 58
IL10_3 & 4R TGCACGTGTGGGTTCAGCCT 60 56 58
IL10_5AF TCCCAGCGTGAGGGAGAACA 60 56
IL10_5AR GCGCCCGGCCTAGAACCAAA 65 58 58
IL10_5BF GTTGAGCTGTTTTCCCTGACCTCCC 56 61
IL10_5BR GTCAGACAAGAGTCAACTGACACCAGA 48 60 61
IL10_5CF CCTAAATTTGGTTCTAGGCCGGGCG 56 61
IL10_5CR TAGGGGGTAGCTGGCTTCCTTTCTC 56 61 61
doi:10.1371/journal.pone.0124559.t002
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chr1:206945616), rs1554286 (2607 C>T, intron 3; chr1:206944233), rs3024496 (4976 T>C, 3’
UTR; chr1:206941864) and rs3024498 (5311 A>G, 3’UTR; chr1:206941529) (Fig 1; Table 3). Of
which, 5311 A>G in 3’UTR is associated with visceral leishmaniasis by logistic regression analysis
(Table 3). Suggesting that allele A is significantly associated with visceral leishmaniasis (χ2 = 18.87;
p = 0.00001, OR = 0.515; CI = 0.382–0.696) (Table 3 and Fig 2A and 2B). However, the ‘G’ allele is
significantly reducing risk of VL (Table 3, Fig 2B). The genotype distribution (%) of 5311 A>G in
VL cases were 49.46 (AA), 29.89 (AG), 20.65 (GG), while in control they were 26.74 (AA), 43.02
(AG), 30.24 (GG) (Table 3 and Fig 2A). All the studied polymorphisms were in HWE for control
subjects. Of these, GG (χ2 = 12.97; p = 0.00032, OR = 0.369; CI = 0.213–0.639) and AG (χ2 = 15.18;
p = 0.00010, OR = .376; CI = 0.228–0.618) genotypes were significantly associated with protection
against VL. Similarly, distributions of allele A was 64.40%, and G was 35.60% in cases; while in con-
trols it was 48.26% (A), and 51.75% (G). Further, of the four SNPs studied, two (rs1554286 and
rs1518111) were in LD in both cases (r2 = 0.78) and controls (r2 = 0.84) (Fig 3).
In-Silico approach for functional validation of rs3024498
Bioinformatic analysis suggest four putative miRNA binding targets at rs3024498; miR-1236
(binding score 140, Δ G -9.20), miR-29b-2 (binding score 150, Δ G -13.80), miR-3192 (binding
score 145, Δ G -23.90) and miR-4321 (binding score 140, Δ G -9.20) in wild type mRNA. In
mutant, only three binding targets were found; miR-1236 (binding score 140, Δ G -9.20), miR-
29b-2 (binding score 145, Δ G -11.20) and miR-3192 (binding score 141, Δ G -23.50).
IL10 variation in diverse Indian populations
Analysis of four IL10 SNPs, observed in case-control study was analysed in 1138 subjects be-
long to 34 populations across India revealed variable frequency. The allele data of rs3024498
Table 3. Distribution of IL10 genotype and alleles in cases and controls of visceral leishmaniasis.
SNP ID Genotype No. of Case (%) No. of Controls (%) OR (95% CI) χ2 Value P- Value Adjusted P-Value
rs1518111 AA 32(17.39) 33(19.19) Ref
AG 83(45.11) 77(44.77) 1.112 0.624–1.979 0.13 0.71912
GG 69(37.50) 62(36.04) 1.148 0.633–2.081 0.21 0.64996
A 147(39.95) 143(41.57) Ref
G 221(60.05) 201(58.43) 1.07 0.793–1.443 0.19 0.65938
rs1554286 CC 60(32.60) 56(32.56) Ref
CT 82(44.57) 74 (43.02) 1.034 0.639–1.673 0.02 0.89091
TT 42(22.83) 42(24.42) 0.933 0.532–1.637 0.06 0.8098
C 202(54.89) 186(54.07) Ref
T 166(45.11) 158(45.93) 0.967 0.720–1.300 0.05 0.82589
rs3024496 CC 30(16.30) 21(12.21) Ref
CT 66(35.87) 64(37.21) 0.722 0.375–1.390 0.95 0.3287
TT 88(47.83) 87(50.58) 0.708 0.377–1.331 1.15 0.28277
C 126(34.24) 106(30.81) Ref
T 242(65.76) 238(69.19) 0.855 0.625–1.171 0.95 0.32983
rs3024498 AA 91(49.46) 46(26.74) Ref
AG 55(29.89) 74(43.02) 0.376 0.228–0.618 15.18 0.0001 0.0004
GG 38(20.65) 52(30.24) 0.369 0.213–0.639 12.97 0.00032 0.0018
A 237(64.40) 166(48.26) Ref
G 131(35.60) 178(51.74) 0.515 0.382–0.696 18.87 0.00001 0.00004
doi:10.1371/journal.pone.0124559.t003
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shows that 24 out of 34 populations have higher frequency (>0.5) of G allele (mostly in tribal
populations), and the remaining 10 populations showed high frequency of A allele (mostly in
caste populations) (Table 4 and Fig 4).
The allele data of rs1554286 has shown that 20 out of 34 populations have higher frequency
(>0.5) of T allele (mostly tribes), 11 populations have high frequency of C allele (mostly castes)
and three populations have an equal frequency of T and C alleles (Table 4 and Fig 4).
The allelic data of rs1518111 has shown that 16 out of 34 populations have higher frequency
(>0.5) of A allele (mostly in tribal populations) and the remaining 18 populations have high
frequency of G allele (mostly in caste populations). The allelic data of rs3024496 shown that all
the populations have higher frequency (>0.5) of T allele (Table 4 and Fig 4).
Discussion
Indian populations are highly diverse due to strict endogamy and show variations in allele fre-
quency in general [37]. Cytokine polymorphisms are usually associated with disease progression.
Fig 2. A. Distribution of genotype frequencies forIL10 polymorphism, rs1518111 A>G; rs1554286 C>T;
rs3024496 C>T and rs3024498 A>G in VL case and control subjects . B. Distribution of allele frequencies
for IL10 polymorphism, rs1518111 A>G; rs1554286 C>T; rs3024496 C>T and rs3024498 A>G in VL case
and control subjects.
doi:10.1371/journal.pone.0124559.g002
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Therefore, our aim was to investigate the IL10 functional variants that can modulate or alter
serum IL10 levels, which may leads to either increased or decreased risk for infectious disease on
whole, VL in particular. Study suggest that about 50% of IL10 production is determined by genet-
ic factors, whereas the other half is accounted by additive environmental influence [42].
We have found a total of 4 SNPs in individuals inhabited in VL endemic regions, of the four
SNPs, rs3024498 showed association with VL. Although this SNP has been found to be associat-
ed with active pulmonary tuberculosis, colorectal cancer, helminth infection, gastrointestinal
stromal tumours and hepatitis C virus (HCV) clearance [19, 43–46], we are reporting for the first
time its association with Indian VL. It has been shown that Indian VL patients exhibit higher lev-
els of IL10 in serum [10, 12, 31]. Since we found g.5311A (A allele of rs3024498) is associated
with VL, we predict that this might be regulating IL10 production, either through cis-regulatory
mechanism or in association (haplotype) with other promoter SNPs. Several studies have estab-
lished that the IL10 gene expression is regulated by complex mechanisms [47–50]. It has also
been demonstrated that the rs3024498 showed similar risk effects in HCV clearance [46].
Haploview analysis of our case-control study shows that the SNP in intron 2 (rs1518111)
is in linkage disequilibrium (r2 = 0.78; Fig 3) with the SNP in intron 3 (rs1554286). Although
Fig 3. Linkage Disequilibrium (LD) of studied IL-10 loci rs1518111 (2195 A>G, intron), rs1554286 (2607 C>T, intron), rs3024496 (4976 T>C, 3’ UTR),
rs3024498 (5311 A>G, 3’ UTR) in VL case and control groups.
doi:10.1371/journal.pone.0124559.g003
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Table 4. Population characteristics (sample size, language family and social designation) and geographical location of studied IL-10 loci
rs1518111 (2195 A>G, intron), rs1554286 (2607 C>T, intron), rs3024496 (4976 T>C, 3’ UTR), rs3024498 (5311 A>G, 3’ UTR) in Indian population.
S.
No.
Population characteristics with demographic details rs1518111 rs1554286 rs302396 rs302398
Population Sample
Size
Language
family
Social
Designation
State/
territory
Latitude /
longitude
A G C T C T A G
1 Tharu 24 Indo-
European
Tribal Uttarakhand 29°23'N/
79°30'E
0.46
(22)
0.46
(26)
0.60
(29)
0.40
(19)
0.17
(8)
0.83
(40)
0.23
(11)
0.77
(37)
2 Gond 24 Dravidian Tribal Jharkhand 22°67'N/
86°33'E
0.46
(22)
0.54
(26)
0.48
(23)
0.52
(25)
0.23
(11)
0.77
(37)
0.06
(3)
0.94
(45)
3 Ho
(Jharkhand)
44 Austro-
Asiatic
Tribal Jharkhand 23°35'N/
85°33'E
0.58
(30)
0.42
(22)
0.42
(22)
0.58
(30)
0.10
(5)
0.90
(47)
0.33
(17)
0.67
(35)
4 Mahali
(Jharkhand)
26 Austro-
Asiatic
Tribal Jharkhand 22°64'N/
86°30'E
0.65
(17)
0.35
(9)
0.42
(11)
0.58
(15)
0.08
(2)
0.92
(24)
0.15
(4)
0.85
(22)
5 Parhaiya 13 Austro-
Asiatic
Tribal Jharkhand 22°60'N/
86°36'E
0.52
(43)
0.48
(39)
0.55
(45)
0.45
(37)
0.24
(20)
0.76
(62)
0.05
(4)
0.95
(78)
6 Gond 41 Dravidian Tribal Chhattisgarh 19°87'N/
81°60'E
0.68
(56)
0.32
(26)
0.28
(23)
0.72
(59)
0.13
(11)
0.87
(71)
0.07
(6)
0.93
(76)
7 Kharia 75 Austro-
Asiatic
Tribal Chhattisgarh 21°90'N/
83°40'E
0.51
(77)
0.49
(73)
0.55
(82)
0.45
(68)
0.17
(25)
0.83
(125)
0.02
(3)
0.98
(147)
8 Bhatudi 38 Indo-
European
Tribal Urissa 21°90'N/
86°70'E
0.59
(45)
0.41
(31)
0.39
(30)
0.61
(46)
0.09
(7)
0.91
(69)
0.29
(22)
0.71
(54)
9 Bhumij 41 Austro-
Asiatic
Tribal Urissa 21°93'N/
86°73'E
0.68
(56)
0.32
(26)
0.34
(28)
0.66
(54)
0.22
(18)
0.78
(64)
0.26
(21)
0.74
(61)
10 Ho (Urissa) 40 Austro-
Asiatic
Tribal Urissa 21°91'N/
86°74'E
0.74
(59)
0.26
(21)
0.25
(20)
0.75
(60)
0.19
(15)
0.81
(65)
0.16
(13)
0.84
(67)
11 Mahali
(Urissa)
46 Austro-
Asiatic
Tribal Urissa 21°93'N/
86°73'E
0.59
(54)
0.41
(38)
0.41
(38)
0.59
(54)
0.12
(11)
0.88
(81)
0.29
(27)
0.71
(65)
12 Korkus 42 Austro-
Asiatic
Tribal Madhya
Pradesh
22°06'N/
78°94'E
0.67
(56)
0.33
(28)
0.32
(27)
0.68
(57)
0.14
(12)
0.86
(72)
0.13
(11)
0.87
(73)
13 Warli 59 Indo-
European
Tribal Maharastra 19°17'N/
72°95'E
0.50
(59)
0.50
(59)
0.44
(52)
0.56
(66)
0.18
(21)
0.82
(97)
0.79
(93)
0.21
(25)
14 Chenchu 20 Dravidian Tribal Andhra
Pradesh
14°41'N/
77°39'E
0.40
(16)
0.60
(24)
0.60
(24)
0.40
(16)
0.25
(10)
0.75
(30)
0.98
(39)
0.03
(1)
15 Raj Gond 28 Dravidian Tribal Andhra
Pradesh
19°67'N/
78°53'E
0.48
(27)
0.52
(29)
0.52
(29)
0.48
(27)
0.23
(13)
0.77
(43)
0.00
(0)
1.00
(56)
16 Kurumba 14 Dravidian Tribal Kerla 10°54'N/
76°27'E
0.46
(13)
0.54
(15)
0.57
(16)
0.43
(12)
0.18
(5)
0.82
(23)
0.07
(2)
0.93
(26)
17 Kashmiri
Pandit
42 Indo-
European
Caste Jammu &
Kashmir
34°22'N/
75°50'E
0.42
(35)
0.42
(49)
0.62
(52)
0.38
(32)
0.26
(22)
0.74
(62)
0.40
(34)
0.60
(50)
18 Pandit 33 Indo-
European
Caste Haryana 31°64'N/
74°86'E
0.42
(28)
0.42
(38)
0.55
(36)
0.45
(30)
0.27
(18)
0.73
(48)
0.85
(56)
0.15
(10)
19 Baiswar 37 Indo-
European
Caste Uttar
Pradesh
25°15'N/
82°60'E
0.36
(27)
0.64
(47)
0.62
(46)
0.38
(28)
0.35
(26)
0.65
(48)
0.95
(70)
0.05
(4)
20 Brahman 36 Indo-
European
Caste Uttar
Pradesh
25°73'N/
82°68'E
0.43
(31)
0.57
(41)
0.46
(33)
0.54
(39)
0.40
(29)
0.60
(43)
0.79
(57)
0.21
(15)
21 Srivastava 17 Indo-
European
Caste Uttar
Pradesh
25°15'N/
82°60'E
0.59
(20)
0.41
(14)
0.53
(18)
0.47
(16)
0.24
(8)
0.76
(26)
0.00
(0)
1.00
(34)
22 Bhilala 41 Indo-
European
Caste Madhya
Pradesh
22°60'N/
75°30'E
0.63
(55)
0.38
(33)
0.22
(19)
0.78
(69)
0.13
(11)
0.88
(77)
0.10
(9)
0.90
(79)
23 Gamit 21 Indo-
European
Caste Gujrat 21°17'N/
72°83'E
0.69
(29)
0.31
(13)
0.29
(12)
0.71
(30)
0.07
(3)
0.93
(39)
0.02
(1)
0.98
(41)
24 Patkar 19 Dravidian Caste Andhra
Pradesh
15°80'N/
78°10'E
0.47
(18)
0.53
(20)
0.63
(24)
0.37
(14)
0.13
(5)
0.87
(33)
0.89
(34)
0.11
(4)
25 Telagas 24 Dravidian Caste Andhra
Pradesh
18°17'N/
83°53'E
0.25
(12)
0.75
(36)
0.73
(35)
0.27
(13)
0.27
(13)
0.73
(35)
0.79
(38)
0.21
(10)
(Continued)
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these two SNPs were not associated with VL in our study, but they were reported with Behcet’s
diseases in Han Chinese, Japan, Turkey and Korea populations [51, 52]. However, in India
SNP rs1554286 has been found to be associated with leprosy [25].
India has one of the richest ethnic and linguistic diversity in South Asia and consists of
more than four thousands of populations, including castes, tribes, primitive tribes and hunters
and gatherers [37]. India is a home of several tribal pockets which represents 8.2% of the total
population (2011 Census). The social structure of the Indian population is governed by the hi-
erarchical caste system. We have demonstrated earlier that every single population in India is
maintaining the endogamy for the last several thousand years, hence gained unique set of varia-
tions, which makes them genetically very distinct [37, 53]. In addition, we have also shown that
the malaria susceptible allele is predominant in some populations, whereas others carry pre-
dominantly resistant allele [54, 55]. Having observed varying frequency of risk / resistant allele
in different Indian populations, it would be worth to assess the frequency of all four IL10 poly-
morphisms, observed in the study, in 34 diverse Indian populations (1138 individuals, across
India; Table 4). We have observed over representation of protective allele (G of rs3024498) for
VL, and risk allele (T of rs1554286) for leprosy among the tribal populations across India, and
vice versa for caste populations (Table 4, Fig 4). Interestingly, alleles A (rs1518111) that was
found to be associated with Behcet’s disease in Han Chinese population [51] was observed pre-
dominantly among the tribes while caste populations have higher frequency (>0.50) of pro-
tected G allele.
Analysis of rs3024498 has shown that majority of tribal populations (14 out of 16), have
high frequency of G allele (>0.50). However, we found only two tribal groups (Chenchu
0.02%; and Warli 0.21%) are with low frequency of G allele, suggesting that these two popula-
tions were under higher risk of VL. Nevertheless, there is no VL case reported neither in these
two populations, nor in these regions (Andhra Pradesh and Maharastra respectively) (Table 4),
which may be due to absence of Leishmania vector and non-favourable ecological conditions.
Interestingly, although Chattisgarh, Jharkhand and Odisha states (tribes dominated states)
Table 4. (Continued)
S.
No.
Population characteristics with demographic details rs1518111 rs1554286 rs302396 rs302398
Population Sample
Size
Language
family
Social
Designation
State/
territory
Latitude /
longitude
A G C T C T A G
26 Thoti 34 Dravidian Caste Andhra
Pradesh
16°51'N/
80°64'E
0.37
(25)
0.63
(43)
0.62
(42)
0.38
(26)
0.16
(11)
0.84
(57)
0.91
(62)
0.09
(6)
27 Pattapu
kapu
23 Dravidian Caste Andhra
Pradesh
15°83'N/
78°05'E
0.43
(20)
0.57
(26)
0.57
(26)
0.43
(20)
0.22
(10)
0.78
(36)
0.07
(3)
0.93
(43)
28 Naidu 21 Dravidian Caste Andhra
Pradesh
13°20'N/
79°11'E
0.40
(17)
0.60
(25)
0.62
(26)
0.38
(16)
0.29
(12)
0.71
(30)
0.02
(1)
0.98
(41)
29 Reddy 22 Dravidian Caste Andhra
Pradesh
17°37'N/
78°48'E
0.25
(11)
0.75
(33)
0.75
(33)
0.25
(11)
0.27
(12)
0.73
(32)
0.05
(2)
0.95
(42)
30 Vysya 55 Dravidian Caste Andhra
Pradesh
14°31'N/
77°44'E
0.45
(49)
0.55
(61)
0.52
(57)
0.48
(53)
0.23
(25)
0.77
(85)
0.04
(4)
0.96
(106)
31 Mala 20 Dravidian Caste Andhra
Pradesh
18°68'N/
78°10'E
0.60
(24)
0.40
(16)
0.48
(19)
0.53
(21)
0.20
(8)
0.80
(32)
0.35
(14)
0.65
(26)
32 AVDV
(Karnataka)
25 Dravidian Caste Karnataka 12°58'N/
77°35'E
0.48
(24)
0.52
(26)
0.60
(30)
0.40
(20)
0.30
(15)
0.70
(35)
0.84
(42)
0.16
(8)
33 Adhi-
dravider
59 Dravidian Caste Tamilnadu 11°35'N/
77°73'E
0.43
(51)
0.57
(67)
0.62
(73)
0.38
(45)
0.19
(23)
0.81
(95)
0.43
(51)
0.57
(67)
34 Mudaliar 34 Dravidian Caste Tamilnadu 12°92'N/
79°13'E
0.59
(40)
0.41
(28)
0.53
(36)
0.47
(32)
0.16
(11)
0.84
(57)
0.88
(60)
0.12
(8)
doi:10.1371/journal.pone.0124559.t004
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were geographically closer to Bihar and majority of the populations inhabited in these states
were genetically protected / frequency of risk alleles is lower (over- representation of G allele of
SNP rs3024498). On the other hand, VL endemic / sporadic states (Bihar, West Bengal and
Eastern part of Uttar Pradesh) were the caste dominated region and show over-representation
of VL associated allele A. Our population data is in concordance with prevalence of VL in
above or different states of India [56].
Fig 4. Geographical location and allele distribution of rs1518111 (2195 A>G, intron), rs1554286 (2607 C>T, intron) and rs3024498 (5311 A>G)
polymorphism in tribe and caste population of India. Population no. 1 to 16 belongs to castes (Fig A, C and E). Population no. 17 to 34 belongs to tribes
(Fig B, D and F).
doi:10.1371/journal.pone.0124559.g004
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Comparison of the allele frequency of rs3024498 in different world populations showed that
it varies across the populations. Interestingly, Gujarati Americans (American citizen with Indi-
an ancestry) of HapMap Phase 3 (GIH) showed low frequency of MAF, compared to our study
(Table 5). This is mainly due to their admixure with the local American (37). Therefore, data of
GIH should not be used as a representative data for Indian population. Analysis of rs3024496
has shown its association with helminth disease and chlamydial infection in Brazil and African
populations, respectively [42, 47], however it is not associated with VL in our study. Although
three SNPs (rs1518111, rs1554286 and rs3024498), out of four showed significant difference
between caste and tribal populations, the fourth SNP (rs3024496) did not show any significant
difference between caste and tribal populations.
Earlier studies on rs1554286 suggest its role in leprosy in North India, where the associated T
allele makes haplotype with promoter SNP [25]. This SNP has been found to be associated with
Behcets disease and down regulates IL10 expression in juvenile rheumatoid arthritis [29, 52].
Analysis of leprosy risk allele T (rs1554286) in different Indian populations showed that majority
of tribal populations (10 out of 16), have higher frequency (>0.50%) of T allele compare to caste
population (4 out of 18) (Table 4). Our data is in concordance with earlier fact that tribe dominat-
ed states (Jharkhand, Chattisgarh and Odisha) were among the high leprosy incidence state in
India according toWorld Health Organization (www.who.int/lep/situation/india/states2006)
(Table 6). Additionally, these states were also malaria endemic region [54]. Variation in rs1518111
Table 5. Observed allele frequencies in the current study compared to reported allele frequencies in world populations.
Hap Map Database Populations rs3024498 (A/G)
A: freq (count) G: freq (count)
This study Case 0.356 (131) 0.644 (237)
Control 0.5174 (178) 0.4826 (166)
Admix Indians Gujarati Indians in Houston, Texas. (GIH) 0.07386 (13) 0.92614 (163)
Europeans Toscans in Italy (TSI) 0.1989 (35) 0.8011 (141)
Cental European (CEU) 0.2909 (64) 0.7091 (156)
Mexicans Mexican ancestry in Los Angeles (MEX) 0.22 (22) 0.78 (78)
E-Asians Han-Chinese-(HCB) 0 (0) 1 (164)
Chinese in Metropolitan Denver, (CHD) 0.006024 (1) 0.993976 (165)
Japanese in Tokyo (JPT) 0 (0) 1 (172)
Africans Luhya in Webuye, Kenya (LWK) 0.1278 (23) 0.8722 (157)
Maasai in Kinyawa, Kenya. (MKK) 0.1573 (45) 0.8427 (241)
Yoruba (YRI) 0.0885 (20) 0.9115 (206)
African ancestry in Southwest USA (ASW) 0.1146 (11) 0.8854 (85)
doi:10.1371/journal.pone.0124559.t005
Table 6. Prevalence (yearly in millions) of different infectious disease (Visceral Leishmaniasis, Leprosy, Tuberculosis Malaria and Filaria) in world-
wide and Indian region.
Diseases Prevalence in
World
Prevalence in
India
Disease burden by region (India-IN / south east asia-
SEA)
Reference
Visceral
Leishmaniasis
~ 0.2–0.4 ~ 0.28 ~67% (SEA) WHO;
(5,38,39,56)
Leprosy ~0.25 ~0.13 ~67 (SEA) WHO; (5,62)
Tuberculosis ~0.88 ~0.22 ~25% (IN) WHO; (5,63)
Malaria ~207 ~0.2 ~77% of south east asia WHO;
(5,54,55,61)
Filaria ~120 ~21 ~26% WHO; (5,64,65)
doi:10.1371/journal.pone.0124559.t006
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was found to be associated with Behcet’s disease in Han Chinese, Japan, Turkey and Korea popu-
lations [51, 52]. Allele wise data indicate that majority of tribal populations (11 out of 16) were
showing high frequency (>0.50%) of A allele, while majority of caste populations (13 out of 18)
shows high frequency of G allele (Table 4). Since study on Han Chinese population shows G allele
as a protective allele, so we can conclude that castes population were resistance for Behcet’s disease
compare to tribes. Our data is in concordance to the fact that Behcet’s disease is very rare in India
due to caste dominated population of India (2011 Census).
Furthermore, Haploview analysis of all four SNPs in 34 diverse Indian populations suggests
that the LD varies from strong to moderate. The majority of the populations analysed (29 out
of 34), showed LD between rs1518111 and rs1554286 (r2>0.5).
Several studies established IL10 as important anti-inflammatory cytokine, which modulate
the VL susceptibility and resistance via Th2/T regulatory responses and considered it as a
master regulator of immunity (reviewed in [9]). Earlier genetic study shows role of IL10 poly-
morphisms in VL, CL and PKDL in different world populations (Iran, Brazil and Sudan)
[34–36]. In India various immunological studies in the same endemic region of Bihar, as the
present study region, have demonstrated that VL patients have higher level of sera IL10,
which is a key regulatory cytokine, involved in inhibition of parasite clearance [10, 32, 33].
Interestingly, our genetic study on the same ethnic populations, showed association of IL10
variation with VL (rs3024498; p = 0.00001). Since the same SNP (rs3024498) along with pro-
moter SNP, was known to involve in phenotype regulation in other population [46], further
analysis of promoter region will help in understanding whether the SNP-rs3024498 alone or
in combination with any promoter SNP leads to VL risk / severity. Additionally, absence of
miR-4321 binding sites and change of binding scores and free energy (miR-29b-2 and miR-
3192) in mutant-rs3024498 (A allele) suggest that this SNP might be dis-regulating the gene
expression through improper miRNA binding, further affecting IL10 production and down-
stream functions of IL10. It is well established fact that genetic variants at miR binding sites
are functional and important contributors to phenotype and diseases variation [57–60]. Pres-
ence of miR binding sites make this SNP relevant for further functional research. Since, di-
verse Indian populations were showing different frequency of risk alleles [54–55]. Therefore,
we have to consider many populations or at least representative populations from different
social and linguistic groups to assess the genetic basis of disease. India is one of major foci of
VL, malaria, leprosy, tuberculosis and filarial infectious diseases however, presence of other
less reported infectious disease in the region, feature a need for further research in this regard
(Table 6) [56, 61–67]. In above context, this study provides valuable information on IL10 var-
iation in Indian populations with disease perspective and demonstrate IL10 association with
VL. Finally, identification of high-risk individuals / populations through genetic analysis will
increase our understanding of the genetic basis of VL and to gain better insight in to the path-
ological basis of the severity of the disease. Thus, further, functional and replication study
from other regions would support to conclude our findings.
Conclusion
In conclusion, we have found a variant g.5311A in IL10, which is associated with Indian VL.
Further, this comprehensive study on IL10 in Indian populations have shown variable frequen-
cy of the disease associated variant in different populations, which is in concordance with our
earlier findings that different social and linguistic populations of India have different genetic
composition that determine the susceptibility or resistance or severity of the disease. Our find-
ing has potential medical implications and this information can be used for generating data on
the neglected diseases and would help in management and forecast of the severity of disease.
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